Roche Holding AG (ROP.SW) Stock Analysis & Winston Score

Roche is a Swiss healthcare company that makes medicines and medical tests. Its pharmaceutical division sells drugs that treat cancer, multiple sclerosis, and other serious diseases, while its diagnostics division makes the machines and test kits that hospitals and labs use to detect illnesses. Roche is one of the largest biotech and diagnostics companies in the world, and it owns well-known cancer drugs like Herceptin, Avastin, and Tecentriq. Roche earns money by selling prescription drugs directly to hospitals and healthcare systems, and by selling diagnostic equipment and consumables to labs worldwide. It operates globally, with strong revenue from the United States, Europe, and Japan, and generates over 260 billion dollars in market value. Its main competitive advantage is its deep pipeline of patented medicines and its unique position as a leader in both drug development and diagnostics. The biggest risk Roche faces is patent expiration on its older blockbuster drugs, which opens the door to cheaper biosimilar competitors eating into sales.